Select Publications

Jackman DM et al. Impact of EGFR and KRAS genotype on outcomes in a clinical
trial registry of NSCLC patients initially treated with erlotinib or gefitinib. Proc ASCO 2008. Abstract 8035.

Patel JD et al. Pemetrexed and carboplatin plus bevacizumab with maintenance
pemetrexed and bevacizumab as first-line therapy for advanced non-squamous nonsmall cell lung cancer (NSCLC). Proc ASCO 2008. Abstract 8004.

Pirker R et al. FLEX: A randomized, multicenter, phase III study of cetuximab in
combination with cisplatin/vinorelbine (CV) versus CV alone in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC). Proc ASCO 2008. Abstract 3.

Riely GJ et al. Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus. Clin Cancer Res 2007;13(17):5150-5. Abstract

Rizvi NA et al. Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer. J Clin Oncol 2008;26(4):639-43. Abstract

Scagliotti GV et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008;26(21):3543-51. Abstract

Van Zandwijk N et al. EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: Retro- and prospective observations in non-small-cell lung cancer. Ann Oncol 2007;18(1):99-103. Abstract

Zhu CQ et al; National Cancer Institute of Canada Clinical Trials Group Study BR.21. Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21. J Clin Oncol 2008;26(26):4268-75. Abstract

Home

EDITOR
Neil Love, MD

INTERVIEWS

David Jablons, MD
- Select publications

Gregory J Riely, MD, PhD
- Select publications

Alan B Sandler, MD
- Select publications

David S Ettinger, MD
- Select publications

Lung Cancer Update:
A CME Audio Series and Activity

Faculty Disclosures

Editor's Office